Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Treatment options in heparin-induced thrombocytopenia.

Hook KM, Abrams CS.

Curr Opin Hematol. 2010 Sep;17(5):424-31. doi: 10.1097/MOH.0b013e32833c07a7. Review.

PMID:
20601872
2.

Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.

Jeske WP, Walenga JM.

Curr Opin Investig Drugs. 2002 Aug;3(8):1171-80. Review.

PMID:
12211410
3.

[Heparin-induced thrombocytopenia].

Cruz-González I, Sánchez-Ledesma M, Sánchez PL, Jang IK.

Rev Esp Cardiol. 2007 Oct;60(10):1071-82. Review. Spanish.

4.

Direct thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.

Lewis BE, Hursting MJ.

Expert Rev Cardiovasc Ther. 2007 Jan;5(1):57-68. Review.

PMID:
17187457
5.

Hitting back HIT.

Gude D.

Ann Card Anaesth. 2012 Apr-Jun;15(2):168-9. doi: 10.4103/0971-9784.95088. No abstract available.

6.

[Bivalirudine in heparin-induced thrombocytopenia].

Gasol-Boncompte M, Gracia-García B, Pastó-Cardona L, Jódar-Masanes R.

Farm Hosp. 2009 Sep-Oct;33(5):285-6. Spanish. No abstract available.

PMID:
19775579
7.

[Heparin-induced thrombocytopenia].

Christoffersen C, Lethagen S, Gøtze JP.

Ugeskr Laeger. 2009 Feb 16;171(8):612-5. Danish.

PMID:
19284907
8.

Heparin-induced thrombocytopenia and cardiovascular diseases.

Das P, Ziada K, Steinhubl SR, Moliterno DJ, Hamdalla H, Jozic J, Mukherjee D.

Am Heart J. 2006 Jul;152(1):19-26. Review. No abstract available.

PMID:
16824828
9.

[Argatroban treatment of heparin-induced immune-mediated thrombocytopenia].

Nielsen JD, Heslet L.

Ugeskr Laeger. 2009 Feb 16;171(8):610-1. Danish.

PMID:
19284906
10.

Heparin-induced thrombocytopenia: treatment options and special considerations.

Dager WE, Dougherty JA, Nguyen PH, Militello MA, Smythe MA.

Pharmacotherapy. 2007 Apr;27(4):564-87. Review.

PMID:
17381384
11.

Alternative methods of anticoagulation for dialysis-dependent patients with heparin-induced thrombocytopenia.

O'Shea SI, Ortel TL, Kovalik EC.

Semin Dial. 2003 Jan-Feb;16(1):61-7. Review.

PMID:
12535303
12.

Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.

Dang CH, Durkalski VL, Nappi JM.

Pharmacotherapy. 2006 Apr;26(4):461-8.

PMID:
16553503
13.

Heparin-induced thrombocytopenia: what clinicians need to know.

Chong BH, Isaacs A.

Thromb Haemost. 2009 Feb;101(2):279-83. Review. No abstract available.

PMID:
19190810
14.

Treatment of heparin-induced thrombocytopenia: is there a role for bivalirudin?

Seybert AL, Coons JC, Zerumsky K.

Pharmacotherapy. 2006 Feb;26(2):229-41. Review.

PMID:
16466327
15.

Bivalirudin.

Warkentin TE, Greinacher A, Koster A.

Thromb Haemost. 2008 May;99(5):830-9. doi: 10.1160/TH07-10-0644. Review.

PMID:
18449412
16.

Heparin-induced thrombocytopenia in the critical care setting: diagnosis and management.

Napolitano LM, Warkentin TE, Almahameed A, Nasraway SA.

Crit Care Med. 2006 Dec;34(12):2898-911. Review.

PMID:
17075368
17.

Heparin-induced thrombocytopenia: a general review.

Swanson JM.

J Infus Nurs. 2007 Jul-Aug;30(4):232-40. Review.

PMID:
17667079
18.

Percutaneous interventions in patients with immune-mediated heparin-induced thrombocytopenia.

Nikolsky E, Dangas GD.

Semin Thromb Hemost. 2004 Jun;30(3):305-14. Review.

PMID:
15282653
19.

Treatment of heparin-induced thrombocytopenia: a critical review.

Hirsh J, Heddle N, Kelton JG.

Arch Intern Med. 2004 Feb 23;164(4):361-9.

PMID:
14980986
20.

Heparin-induced thrombocytopenia in intensive care patients.

Selleng K, Warkentin TE, Greinacher A.

Crit Care Med. 2007 Apr;35(4):1165-76. Review.

PMID:
17334253
Items per page

Supplemental Content

Write to the Help Desk